No Data
Jafron Biomedical (300529.SZ): Plasma separators have obtained EU MDR certification.
Jafron Biomedical (300529.SZ) announced that its wholly-owned subsidiary Zhuhai Jafron Blood Purification Technology Co., Ltd. (abbreviated...
Is Jafron BiomedicalLtd (SZSE:300529) A Risky Investment?
CEO Fan Dong, Jafron Biomedical Co.,Ltd.'s (SZSE:300529) Largest Shareholder Sees Value of Holdings Go Down 4.5% After Recent Drop
jafron biomedical (300529.SZ): Appointed Li Feng as the company's vice general manager
Galunhui November 21st | Jafron Biomedical (300529.SZ) announced that the board of directors approved the appointment of Mr. Li Feng as the company's deputy general manager, with a term from the date of this board of directors' approval to the end of the fifth session of the board of directors. As of the date of this announcement, Mr. Li Feng directly holds 0.7558 million shares of the company, accounting for 0.09% of the total share capital; holds 3 million shares of the company's Striver No. 1 employee stock ownership plan, accounting for 2.2% of the total plan shares, converted through the employee stock ownership plan to indirectly hold 0.1225 million shares, accounting for 0.02% of the total share capital. He holds shares through
Jafron BiomedicalLtd's (SZSE:300529) 84% YoY Earnings Expansion Surpassed the Shareholder Returns Over the Past Year
Jafron Biomedical Co.,Ltd. Just Missed Revenue By 8.1%: Here's What Analysts Think Will Happen Next
Jafron BiomedicalLtd's (SZSE:300529) Earnings Trajectory Could Turn Positive as the Stock Increases 7.1% This Past Week
No Data
